Friday, May 06, 2011 12:09:13 PM
Adding new production would cost a measly sum ($50ish mil, max) but it would take years to complete and get approved. I'm guessing it's the 'time' that is holding them back.>>
But the objective is to maximize profit, not revenue. You are assuming that if Sandoz/Momenta increases capacity significantly above 50%, that Sanofi does nothing in response, no price war,. no authorized generic, they just sit there and watch their market share and profit go down. Sort of like Johnny Tyler in Tombstone (Wyatt Earp: You gonna do somethin'? Or are you just gonna stand there and bleed?)
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
